Kate Garrett has more than 17 years of experience in the medical device industry as a serial inventor, entrepreneur and operator across the spectrum of early stage start-up to large multi-national organizations. Prior to Sonder Capital, Ms. Garrett co-founded Ciel Medical, a critical care company, where as CEO she led a team in the invention, development and commercialization of three products for ventilated patients. Ciel was acquired by Vyaire Medical in 2017 and Ms. Garrett transitioned to Vice President of Airway Technologies at Vyaire. Previously, she was a strategic marketing consultant at Acclarent and a R&D Engineer at Pathway Medical. Ms. Garrett has co-authored over a dozen patents including technologies in urology, critical care, women’s health and vascular surgery. She currently serves as Chairman of Brius and is a director at Ziteo, Spirair, and Neptune. Additionally, she is the Assistant Director of the Stanford Biodesign Innovation Fellowship.

Ms. Garrett has received multiple honorary fellowships including being one of the first recipients of the Ferolyn Fellowship. Ms. Garrett holds a B.S. in Mechanical Engineering from Franklin W. Olin College of Engineering and is a graduate of the Stanford University Biodesign fellowship.